T.P. Devarajan
Managing Director @ InvAscent
Hyderabad, India
T.P. Devarajan is a Series B investor at InvAscent in Hyderabad focused on Health Care and Medical. T.P. Devarajan is the Managing Director of InvAscent.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries T.P. Devarajan invests in
Stages T.P. Devarajan invests in
Countries T.P. Devarajan invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (50%)
- Medical 1 (25%)
- mHealth 1 (25%)
- Consulting 1 (25%)
- Biotechnology 1 (25%)
Stage
- Series B 1 (25%)
- Funding Round 1 (25%)
- Private Equity 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- India 2 (50%)
- United States 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Malladi Drugs
|
Malladi is a manufacturer of active pharmaceutical ingredients in the cough and cold segment of the global pharmaceutical industry and therapeutic segments such as antihistamines, anticonvulsants, antidepressants, and anxiolytics. The company's products and services to the benefit of society. | $32.7M / Private Equity / Apr 25, 2022 | |
MediSage
|
Medisage is a global community of Doctors Connect with Global doctors, watch video case studies by subject matter experts, read latest medical news and discuss patient cases. | $6.3M / Apr 13, 2022 | |
|
MediSage
|
Medisage is a global community of Doctors Connect with Global doctors, watch video case studies by subject matter experts, read latest medical news and discuss patient cases. | $7M / Venture - Series Unknown / Apr 13, 2022 | |
MediBuddy
|
MediBuddy is a digital healthcare platform for an inpatient hospitalization, outpatient services, and corporate wellness benefits.MediBuddy is the award-winning technology platform from Medi Assist that transforms the health insurance industry at the very core. MediBuddy, with its diverse offerings for various stakeholders of the health benefitsindustry, makes the process of discovering, accessing, utilizing, and monitoring health benefits seamless, real-time, and virtually paperless. The company was founded in 2000 and based in Bangalore, Karnataka, India. | $40M / Series B / Feb 02, 2021 |
Co-Investors
About InvAscent
InvAscent is the investment advisor to EILSF (Fund I), India Life Sciences Fund II (ILSF-II) and India Life Sciences Fund III (ILSF-III). These funds provide private equity growth capital to companies in the Indian pharmaceutical, healthcare, animal health and medtech industries. Examples of funds usage include capacity expansion, introduction ofnew products, acquisitions, etc. The typical investment size is in the range of USD 10 - 40 million over the life of the investment for a significant minority stake.
InvAscent Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hari Buggana
Founder, Chairman and Managing Director
|
|||
|
T.P. Devarajan
Managing Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does T.P. Devarajan invest in?
T.P. Devarajan invests primarily in Health Care, Medical and mHealth startups, most often at Series B and Funding Round stage. Most of the 4 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact T.P. Devarajan?
Public channels for T.P. Devarajan include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did T.P. Devarajan last invest?
The most recent investment recorded for T.P. Devarajan closed in Apr 2022. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
